Cryoablation Devices Market (By Product: Tissue Contact Probe Ablators, Tissue Spray Probe Ablators; By Application: Lung Cancer, Breast Cancer; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The global cryoablation devices market was valued at USD 183.89 million in 2022 and it is predicted to surpass around USD 418.09 million by 2032 with a CAGR of 8.56% from 2023 to 2032.

Cryoablation Devices Market Size 2023 to 2032

Cryoablation devices offer various benefits such as fewer side effects, easy recovery, cost-effective, etc. These benefits represent lucrative growth opportunities for the cryoablation market. In addition, new product launches and various studies being carried out by the government authorities, to broaden the application of cryoablation is also driving the growth of the market. For instance, November 2019, National Cancer Institute, launched the study to determine the effect of cryoablation on adaptive resistance to immunotherapy in metastatic cancer patients. 

Report Scope of the Cryoablation Devices Market

Report Coverage Details
Market Size in 2022 USD 183.89 million
Revenue Forecast by 2032 USD 418.09 million
Growth rate from 2023 to 2032 CAGR of 8.56%
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Increasing prevalence of cancer such as lung and prostrate cancer and cardiac arrhythmia is another major factor boosting the growth of cryoablation market. According to study published by CDC, in October 2022, an estimated 12.1 million U.S. citizens will have Atrial Fibrillation in 2030. On the other hand, according to the American Society of Clinical Oncology, in 2020, an estimated 1.4 million men were diagnosed with prostate cancer, globally.

Increasing preference for minimally invasive surgeries is another factor driving the growth of the market. Preference for a good cosmetic outcome has led to shift towards breast-conserving, minimally invasive procedures such as radiotherapy and ablation therapies instead of surgery.

Based on application, the cardiac arrhythmia segment is expected to experience maximum growth owing to increasing prevalence and rising efforts of manufacturers to develop and expand the application of their products to treat this condition. While the breast cancer segment dominated the market due to increasing adoption of cryoablation devices in treatment of breast cancer.

Key players operating in the cryoablation devices market includes Boston Scientific, MicroPort Scientific Corporation, Medtronic Plc., CooperSurgical Inc., AtriCure Inc., Galil Medical, BVM Medical Limited, CPSI Biotech, HealthTronics, Inc., IceCure Medical and METRUM CRYOFLEX Sp. Manufacturers in the Market are focusing on launching new products in the market and expanding the application of the products that are already a part of their product portfolio. For instance, In February 2022, Medtronic Plc, received an expanded FDA approval for its Freezorand FreezorXtra Cardiac Cryoablation Focal Catheters to treat the growing prevalence of pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).

Cryoablation Devices Market Segmentations:

By Product By Application By End-Use

Tissue Contact Probe Ablators

Epidermal and Subcutaneous Cryoablation Systems

Tissue Spray Probe Ablators

Lung Cancer

Liver Cancer

Breast Cancer

Kidney Cancer

Prostate Cancer

Cardiac Arrhythmia

Hospitals

Ambulatory surgical centers

Specialty Clinics

Others

Frequently Asked Questions

The global cryoablation devices market size was reached at USD 183.89 million in 2022 and it is projected to hit around USD 418.09 million by 2032.

The global cryoablation devices market is growing at a compound annual growth rate (CAGR) of 8.56% from 2023 to 2032.

The North America region has accounted for the largest cryoablation devices market share in 2022.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Product Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cryoablation Devices Market 

5.1. COVID-19 Landscape: Cryoablation Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cryoablation Devices Market, By Product

8.1. Cryoablation Devices Market, by Product, 2023-2032

8.1.1 Tissue Contact Probe Ablators

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Epidermal and Subcutaneous Cryoablation Systems

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Tissue Spray Probe Ablators

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Cryoablation Devices Market, By Application

9.1. Cryoablation Devices Market, by Application, 2023-2032

9.1.1. Lung Cancer

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Liver Cancer

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Breast Cancer

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Kidney Cancer

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Prostate Cancer

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Cardiac Arrhythmia

9.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Cryoablation Devices Market, By End-Use 

10.1. Cryoablation Devices Market, by End-Use, 2023-2032

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Ambulatory surgical centers

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Specialty Clinics

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Leisure & Entertainment

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Cryoablation Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.4.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.5.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.4.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.5.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.6.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.7.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.4.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.5.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.6.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.7.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.4.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.5.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.6.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.7.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.4.3. Market Revenue and Forecast, by End-Use (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.5.3. Market Revenue and Forecast, by End-Use (2020-2032)

Chapter 12. Company Profiles

12.1. Boston Scientific

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. MicroPort Scientific Corporation

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Medtronic Plc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. CooperSurgical Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. AtriCure Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Galil Medical

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. BVM Medical Limited

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. CPSI Biotech

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. HealthTronics, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. IceCure Medical

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers